![Patrick Taylor Horn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Taylor Horn
Keine laufenden Positionen mehr
Profil
Patrick Taylor Horn formerly worked at Abbott Laboratories, as Medical Director & Head-Clinical Pharmacology in 2006, Dyax Corp., as Vice President-Clinical & Medical Affairs in 2010, Tetraphase Pharmaceuticals, Inc., as Chief Medical Officer from 2011 to 2017, Orphan Technologies Ltd., as Senior VP-Medical & Clinical Development in 2018, Albireo Pharma, Inc., as Chief Medical Officer from 2018 to 2021, HemoShear Therapeutics, Inc., as Chief Medical Officer, and Fulcrum Therapeutics, Inc., as Chief Medical Officer.
Dr. Horn received his doctorate degree from The University of Chicago, undergraduate degree from the University of Illinois, and doctorate degree from Pritzker School of Medicine.
Ehemalige bekannte Positionen von Patrick Taylor Horn
| Unternehmen | Position | Ende |
|---|---|---|
| ALBIREO PHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2021 |
Orphan Technologies Ltd.
 Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs | Corporate Officer/Principal | 01.07.2018 |
| TETRAPHASE PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 29.12.2017 |
| DYAX CORP. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2010 |
| ABBOTT LABORATORIES | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 |
Ausbildung von Patrick Taylor Horn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
HemoShear Therapeutics, Inc.
 HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services Creates human relevant systems that replicate the biology of organ systems and diseases | Health Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pritzker School of Medicine
 Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orphan Technologies Ltd.
Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs | Health Technology |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Wählen Sie MarketScreener 
